Corporate Finance, DeFi, Blockchain, Web3 News
Corporate Finance, DeFi, Blockchain News

Thorn Medical PLC Appoints Roderick Stead as Group Finance Director

Thorn Medical PLC ("Thorn" or the "Company"), the international healthcare group, today announces the appointment of Roderick Stead as Group Finance Director, with immediate effect.

Mr Stead joins the Board from PTS Consulting, the global IT Consulting and Project Management firm, for whom he arranged a management buyout in 1990 and served in a number of capacities including Chief Financial Officer, during which time the company increased in size by 600%, competed a number of local and international acquisitions and secured growth capital investment. Subsequent roles included Chief Risk Officer, when he established a Compliance, Legal & Risk function, and Non-Executive Director.

Prior to that, Mr Stead qualified as a Chartered Accountant with Arthur Anderson before moving into a number of commercially-engaged finance roles, before moving into financial consulting, specializing in working with companies in financial difficulty.

Jack Kaye, Thorn Medical's Chief Executive, said: "We're delighted to welcome Roderick Stead to the Board as Group Finance Director. His experience in fundraising and international acquisitions will be a great help to achieving our challenging global expansion plans."

Roderick Stead added, "Thorn Medical has ambitious plans for growing the company rapidly to become a major international force in the medical and healthcare arena and I look forward to working with the team to ensure its success."

Thorn Medical PLC
Thorn Medical is a trusted expert investor and acceleration partner dedicated to breaking down the barriers to providing more efficient and effective healthcare worldwide.
With a clear focus on improving human wellbeing, it acts as an aggregator of innovative, scientifically-validated medical technology, pharmaceutical products and healthcare services businesses.
It aims to transform organisational performance through delivering best practice flexible management services that streamline operations, reduce costs, encourage cross-fertilisation, expand market reach and enhance return on capital.
Thorn Medical is dedicated to this market, with a global perspective and an understanding at first hand of the evolving challenges that healthcare businesses face in growing successfully.
Thorn Medical understands how to create value for investors, service providers and patients through building a balanced portfolio of pre-and post-revenue companies that specialise in commercialising innovative and medical technologies and services.
Thorn Medical will continue to grow both organically and through acquisitions, continually developing the enterprise and fully addressing the human health cycle and its genetic, environmental, physical and nutritional influencing factors.
Thorn Medical focuses on four areas
- Disease prevention
- Immunity optimisation
- Disease treatment
- Research & development

Les médias du groupe Finyear

Mardi 10 Mai 2016